已收盤 09-18 16:00:00 美东时间
-0.250
-6.08%
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts jus...
08-20 21:00
Elutia Inc. (NASDAQ:ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix products, today announced that it had received gross proceeds of approximately $15.7 million from the exercise of outstanding
08-02 04:47
Despite an already strong run, Elutia Inc. (NASDAQ:ELUT) shares have been power...
07-04 19:10
Cantor Fitzgerald analyst Ross Osborn maintains Elutia (NASDAQ:ELUT) with a Overweight and raises the price target from $5 to $11.
06-19 04:57
An update from Aziyo Biologics (ELUT) is now available. Elutia Inc. announced t...
06-17 23:14
Elutia shares are trading lower after the company announced a $13.26 million re...
06-17 20:19
EluPro becomes the only drug-eluting biologic envelope to receive FDA clearance in the $600 million U.S. implantable electronic device protection market EluPro also granted clearance for indications beyond CIEDs,
06-17 20:03
Gainers Elutia (NASDAQ:ELUT) stock rose 24.2% to $4.31 during Tuesday's regula...
06-12 00:31
12月31日,Elutia, Inc.(ELUT.US)公布财报,公告显示公司2023财年净利润为-41.25百万美元,同比减少25.38%;其中营业收入为2...
03-10 00:25
Elutia (NASDAQ:ELUT) reported its Q4 earnings results on Thursday, March 7, 202...
03-08 05:25